| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8133883 | WYETH PHARMS | Compositions containing piperacillin and tazobactam useful for injection |
Apr, 2023
(1 year, 11 days ago) | |
| US6900184 | WYETH PHARMS | Compositions containing pipercillin and tazobactam useful for injection |
Apr, 2023
(1 year, 11 days ago) | |
| US7915229 | WYETH PHARMS | Compositions containing piperacillin and tazobactam useful for injection |
Apr, 2023
(1 year, 11 days ago) | |
Zosyn is owned by Wyeth Pharms.
Zosyn contains Piperacillin Sodium; Tazobactam Sodium.
Zosyn has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Zosyn are:
- US8133883
- US6900184
- US7915229
Zosyn was authorised for market use on 22 October, 1993.
Zosyn is available in injectable;injection dosage forms.
Zosyn can be used as method of treating bacterial infections.
The generics of Zosyn are possible to be released after 14 April, 2023.
Drugs and Companies using PIPERACILLIN SODIUM; TAZOBACTAM SODIUM ingredient
Market Authorisation Date: 22 October, 1993
Treatment: Method of treating bacterial infections
Dosage: INJECTABLE;INJECTION
How can I launch a generic of ZOSYN before it's drug patent expiration?
More Information on Dosage
ZOSYN family patents
